SG Americas Securities’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90K | Sell |
19,293
-51,206
| -73% | -$239K | ﹤0.01% | 2353 |
|
|
2025
Q1 | $387K | Sell |
70,499
-24,172
| -26% | -$133K | ﹤0.01% | 1785 |
|
|
2024
Q4 | $321K | Buy |
94,671
+34,469
| +57% | +$117K | ﹤0.01% | 1521 |
|
|
2024
Q3 | $172K | Buy |
60,202
+39,335
| +189% | +$112K | ﹤0.01% | 2325 |
|
|
2024
Q2 | $47K | Sell |
20,867
-150
| -0.7% | -$338 | ﹤0.01% | 2319 |
|
|
2024
Q1 | $46K | Sell |
21,017
-12,760
| -38% | -$27.9K | ﹤0.01% | 2446 |
|
|
2023
Q4 | $79K | Buy |
33,777
+15,414
| +84% | +$36.1K | ﹤0.01% | 2582 |
|
|
2023
Q3 | $34K | Buy |
+18,363
| New | +$34K | ﹤0.01% | 2685 |
|
|
2023
Q2 | – | Sell |
-40,947
| Closed | -$67K | – | 2890 |
|
|
2023
Q1 | $67K | Buy |
+40,947
| New | +$67K | ﹤0.01% | 2751 |
|
|
2022
Q4 | – | Sell |
-25,397
| Closed | -$40K | – | 3010 |
|
|
2022
Q3 | $40K | Buy |
+25,397
| New | +$40K | ﹤0.01% | 2700 |
|
|
2021
Q3 | – | Sell |
-244,228
| Closed | -$994K | – | 3504 |
|
|
2021
Q2 | $994K | Buy |
+244,228
| New | +$994K | ﹤0.01% | 1417 |
|
|
2020
Q3 | – | Sell |
-20,438
| Closed | -$54K | – | 2967 |
|
|
2020
Q2 | $54K | Buy |
20,438
+7,215
| +55% | +$19.1K | ﹤0.01% | 3054 |
|
|
2020
Q1 | $26K | Buy |
+13,223
| New | +$26K | ﹤0.01% | 2761 |
|